博迅生物
(836504)
| 流通市值：4.62亿 | | | 总市值：11.72亿 |
| 流通股本：1709.77万 | | | 总股本：4333.31万 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 37,429,456.89 | 76,433,131.18 | 18,480,719.95 | 44,750,712.18 |
| 应收票据及应收账款 | 24,569,301.81 | 12,865,554.93 | 27,926,909.03 | 30,344,889.2 |
| 其中：应收票据 | 5,769,346.8 | 9,335,397.23 | 5,782,903.15 | 3,644,086.88 |
| 应收账款 | 18,799,955.01 | 3,530,157.7 | 22,144,005.88 | 26,700,802.32 |
| 应收款项融资 | 18,737 | 2,965,634.83 | 1,163,932.86 | 803,417.42 |
| 预付款项 | 2,817,637.89 | 1,677,942.8 | 1,997,955.96 | 2,083,859.18 |
| 其他应收款合计 | 181,047.96 | 40,532.02 | 240,215.74 | 179,395.96 |
| 其中:应收利息 | 26,852.06 | 2,441.1 | 34,939.74 | 5,449.32 |
| 存货 | 26,683,117.93 | 26,089,113.71 | 28,918,802.91 | 30,614,379.35 |
| 一年内到期的非流动资产 | 22,341,513.23 | 22,181,988.11 | 21,984,835.35 | 1,200,335.35 |
| 其他流动资产 | 2,469,872.82 | 3,616,081.12 | 2,924,261 | 2,677,524.21 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 167,175,314.31 | 174,703,160.23 | 184,696,788.75 | 154,093,942.57 |
| 非流动资产: | | | | |
| 长期应收款 | 15,570,651.74 | 15,507,416.09 | 16,559,909.72 | 16,409,947.45 |
| 固定资产 | 23,193,411.16 | 22,138,713.66 | 17,890,325.75 | 18,272,878.74 |
| 在建工程 | 18,983,794.28 | 17,936,265.66 | 19,334,478.29 | 18,625,338.6 |
| 使用权资产 | 4,709,926.72 | 4,941,799.54 | 5,173,672.36 | 5,405,545.18 |
| 无形资产 | 9,719,863.74 | 9,636,382.76 | 9,410,167.13 | 9,511,820.81 |
| 长期待摊费用 | 2,778,695.43 | 2,963,145.99 | 489,042.87 | 575,977.83 |
| 递延所得税资产 | 3,806,286.69 | 4,016,672.06 | 4,154,243.45 | 3,909,977.56 |
| 其他非流动资产 | - | - | - | 20,646,500 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 78,762,629.76 | 77,140,395.76 | 73,011,839.57 | 93,357,986.17 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 245,937,944.07 | 251,843,555.99 | 257,708,628.32 | 247,451,928.74 |
| 流动负债: | | | | |
| 短期借款 | - | - | 10,000,000 | 10,000,000 |
| 应付票据及应付账款 | 14,692,940.64 | 18,265,023.44 | 15,543,625.02 | 14,924,969.34 |
| 应付账款 | 14,692,940.64 | 18,265,023.44 | 15,543,625.02 | 14,924,969.34 |
| 合同负债 | 1,322,846.27 | 2,131,821.91 | 3,259,362.8 | 951,914.37 |
| 应付职工薪酬 | 2,108,178.84 | 2,865,878.31 | 2,152,741.81 | 2,197,618.34 |
| 应交税费 | 2,156,754.33 | 1,817,655.93 | 2,428,505.47 | 3,487,571.51 |
| 其他应付款合计 | 2,933,251.81 | 5,657,473.91 | 3,885,904.11 | 2,320,885.17 |
| 一年内到期的非流动负债 | 2,063,245.44 | 1,959,179.67 | 2,003,228.67 | 2,003,228.67 |
| 其他流动负债 | 6,322,153.32 | 6,012,906.94 | 4,974,228.58 | 2,477,955.4 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 31,599,370.65 | 38,709,940.11 | 44,247,596.46 | 38,364,142.8 |
| 非流动负债: | | | | |
| 租赁负债 | 18,041,704.03 | 17,990,402.69 | 19,373,901.09 | 19,207,657 |
| 递延收益 | 1,164,250 | 1,219,000 | 1,273,750 | 1,328,500 |
| 递延所得税负债 | 234,722.15 | 265,964.28 | 289,714.83 | 319,030.29 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 19,440,676.18 | 19,475,366.97 | 20,937,365.92 | 20,855,187.29 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 51,040,046.83 | 58,185,307.08 | 65,184,962.38 | 59,219,330.09 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 43,333,100 | 43,333,100 | 43,333,100 | 43,333,100 |
| 资本公积 | 114,590,131.66 | 114,590,131.66 | 114,590,131.66 | 114,590,131.66 |
| 盈余公积 | 18,611,085.85 | 18,611,085.85 | 16,737,149.39 | 16,737,149.39 |
| 未分配利润 | 18,363,579.73 | 17,123,931.4 | 17,863,284.89 | 13,572,217.6 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 194,897,897.24 | 193,658,248.91 | 192,523,665.94 | 188,232,598.65 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 194,897,897.24 | 193,658,248.91 | 192,523,665.94 | 188,232,598.65 |
| 负债和股东权益合计 | 245,937,944.07 | 251,843,555.99 | 257,708,628.32 | 247,451,928.74 |
| 公告日期 | 2025-04-28 | 2025-04-07 | 2024-10-30 | 2024-08-21 |
| 审计意见(境内) | | 标准无保留意见 | | |